Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01852201 · ClinicalTrials.gov registry record · NA
POSITIVE Stroke Clinical Trial
A NA study, sponsored by Medical University of South Carolina.
- Terminated
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT01852201 is a NA study that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 33 participants.
The verdict
NCT01852201, a NA study, was terminated before completion, sponsored by Medical University of South Carolina.
- TERMINATED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Primary Endpoint: The primary objective is to show that AIS patients, ineligible for or refractory to treatment with IV-tPA, with appropriate image selection, treated with mechanical thrombectomy within 6-12 hours of symptom onset have less stroke related disability and improved good functional outcomes as compared to those treated with best MT with respect to endpoint defined as: • 90-day global disability assessed via the modified Rankin score (mRS), analyzed using raw mRS scores. Statistical details can be found in section 7.2. Secondary Endpoints: * 90-day global disability in the 6-12 hr cohort assessed via the overall distribution of mRS * Proportion of patients with good functional recovery for the 6-12 hr cohort as defined by mRS 0-2 at 90 days * Mortality at 30 and 90 days * Intracranial hemorrhage with neurological deterioration (NIHSS worsening \>4) within 24 hours of randomization * Procedure related serious adverse events (SAE's) * Arterial revascularization measured by TICI 2b or 3 following device use
Interventions
- DEVICE Endovascular Mechanical Thrombectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2013-09 |
| Est. Completion | 2017-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01852201
The ClinicalTrials.gov registry entry for NCT01852201 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Endovascular Mechanical Thrombectomy is the first listed.
NCT01852201 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01852201 about?
NCT01852201 is a clinical study titled "POSITIVE Stroke Clinical Trial". Primary Endpoint: The primary objective is to show that AIS patients, ineligible for or refractory to treatment with IV-tPA, with appropriate image selection, treated with mechanical thrombectomy within 6-12 hours of symptom onset have less stroke related disability and improved good functional out...
What is the current status of trial NCT01852201?
This trial is currently terminated. It is a NA study. The enrollment target is 33 participants. The study started on 2013-09. Estimated completion is 2017-05-31.
What interventions are being tested in trial NCT01852201?
The interventions under investigation include: Endovascular Mechanical Thrombectomy (DEVICE).
Who is sponsoring clinical trial NCT01852201?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.